Global Adoptive Cell Transfer Therapy Market Growth (Status and Outlook) 2023-2028

Report ID: 1479576 | Published Date: Oct 2024 | No. of Page: 122 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Adoptive Cell Transfer Therapy Market Size 2017-2028
        2.1.2 Adoptive Cell Transfer Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Adoptive Cell Transfer Therapy Segment by Type
        2.2.1 NK
        2.2.2 LAK
        2.2.3 DC
        2.2.4 CIK
        2.2.5 CTL
        2.2.6 TIL
        2.2.7 TCR-T
        2.2.8 CAR-T
    2.3 Adoptive Cell Transfer Therapy Market Size by Type
        2.3.1 Adoptive Cell Transfer Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
    2.4 Adoptive Cell Transfer Therapy Segment by Application
        2.4.1 Acute Lymphocytic Leukemia
        2.4.2 NHL
        2.4.3 Melanoma
        2.4.4 Bladder Cancer
        2.4.5 Lung Cancer
        2.4.6 Head and Neck Cancer
        2.4.7 Multiple Myeloma
        2.4.8 Other
    2.5 Adoptive Cell Transfer Therapy Market Size by Application
        2.5.1 Adoptive Cell Transfer Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
3 Adoptive Cell Transfer Therapy Market Size by Player
    3.1 Adoptive Cell Transfer Therapy Market Size Market Share by Players
        3.1.1 Global Adoptive Cell Transfer Therapy Revenue by Players (2020-2022)
        3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2020-2022)
    3.2 Global Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Adoptive Cell Transfer Therapy by Regions
    4.1 Adoptive Cell Transfer Therapy Market Size by Regions (2017-2022)
    4.2 Americas Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)
    4.3 APAC Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)
    4.4 Europe Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)
    4.5 Middle East & Africa Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
    5.2 Americas Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
    5.3 Americas Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Adoptive Cell Transfer Therapy Market Size by Region (2017-2022)
    6.2 APAC Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
    6.3 APAC Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Adoptive Cell Transfer Therapy by Country (2017-2022)
    7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
    7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Adoptive Cell Transfer Therapy by Region (2017-2022)
    8.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
    8.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Adoptive Cell Transfer Therapy Market Forecast
    10.1 Global Adoptive Cell Transfer Therapy Forecast by Regions (2023-2028)
        10.1.1 Global Adoptive Cell Transfer Therapy Forecast by Regions (2023-2028)
        10.1.2 Americas Adoptive Cell Transfer Therapy Forecast
        10.1.3 APAC Adoptive Cell Transfer Therapy Forecast
        10.1.4 Europe Adoptive Cell Transfer Therapy Forecast
        10.1.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast
    10.2 Americas Adoptive Cell Transfer Therapy Forecast by Country (2023-2028)
        10.2.1 United States Adoptive Cell Transfer Therapy Market Forecast
        10.2.2 Canada Adoptive Cell Transfer Therapy Market Forecast
        10.2.3 Mexico Adoptive Cell Transfer Therapy Market Forecast
        10.2.4 Brazil Adoptive Cell Transfer Therapy Market Forecast
    10.3 APAC Adoptive Cell Transfer Therapy Forecast by Region (2023-2028)
        10.3.1 China Adoptive Cell Transfer Therapy Market Forecast
        10.3.2 Japan Adoptive Cell Transfer Therapy Market Forecast
        10.3.3 Korea Adoptive Cell Transfer Therapy Market Forecast
        10.3.4 Southeast Asia Adoptive Cell Transfer Therapy Market Forecast
        10.3.5 India Adoptive Cell Transfer Therapy Market Forecast
        10.3.6 Australia Adoptive Cell Transfer Therapy Market Forecast
    10.4 Europe Adoptive Cell Transfer Therapy Forecast by Country (2023-2028)
        10.4.1 Germany Adoptive Cell Transfer Therapy Market Forecast
        10.4.2 France Adoptive Cell Transfer Therapy Market Forecast
        10.4.3 UK Adoptive Cell Transfer Therapy Market Forecast
        10.4.4 Italy Adoptive Cell Transfer Therapy Market Forecast
        10.4.5 Russia Adoptive Cell Transfer Therapy Market Forecast
    10.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast by Region (2023-2028)
        10.5.1 Egypt Adoptive Cell Transfer Therapy Market Forecast
        10.5.2 South Africa Adoptive Cell Transfer Therapy Market Forecast
        10.5.3 Israel Adoptive Cell Transfer Therapy Market Forecast
        10.5.4 Turkey Adoptive Cell Transfer Therapy Market Forecast
        10.5.5 GCC Countries Adoptive Cell Transfer Therapy Market Forecast
    10.6 Global Adoptive Cell Transfer Therapy Forecast by Type (2023-2028)
    10.7 Global Adoptive Cell Transfer Therapy Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Novartis AG
        11.1.1 Novartis AG Company Information
        11.1.2 Novartis AG Adoptive Cell Transfer Therapy Product Offered
        11.1.3 Novartis AG Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Novartis AG Main Business Overview
        11.1.5 Novartis AG Latest Developments
    11.2 Kite Pharma
        11.2.1 Kite Pharma Company Information
        11.2.2 Kite Pharma Adoptive Cell Transfer Therapy Product Offered
        11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Kite Pharma Main Business Overview
        11.2.5 Kite Pharma Latest Developments
    11.3 Pfizer
        11.3.1 Pfizer Company Information
        11.3.2 Pfizer Adoptive Cell Transfer Therapy Product Offered
        11.3.3 Pfizer Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Pfizer Main Business Overview
        11.3.5 Pfizer Latest Developments
    11.4 Juno Therapeutics
        11.4.1 Juno Therapeutics Company Information
        11.4.2 Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
        11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Juno Therapeutics Main Business Overview
        11.4.5 Juno Therapeutics Latest Developments
    11.5 Celgene Corporation
        11.5.1 Celgene Corporation Company Information
        11.5.2 Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
        11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Celgene Corporation Main Business Overview
        11.5.5 Celgene Corporation Latest Developments
    11.6 CARsgen Therapeutics
        11.6.1 CARsgen Therapeutics Company Information
        11.6.2 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
        11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 CARsgen Therapeutics Main Business Overview
        11.6.5 CARsgen Therapeutics Latest Developments
    11.7 Sorrento Therapeutics
        11.7.1 Sorrento Therapeutics Company Information
        11.7.2 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
        11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Sorrento Therapeutics Main Business Overview
        11.7.5 Sorrento Therapeutics Latest Developments
    11.8 Legend Biotech
        11.8.1 Legend Biotech Company Information
        11.8.2 Legend Biotech Adoptive Cell Transfer Therapy Product Offered
        11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Legend Biotech Main Business Overview
        11.8.5 Legend Biotech Latest Developments
    11.9 Atara Biotherapeutics
        11.9.1 Atara Biotherapeutics Company Information
        11.9.2 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
        11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Atara Biotherapeutics Main Business Overview
        11.9.5 Atara Biotherapeutics Latest Developments
    11.10 Aurora Biopharma
        11.10.1 Aurora Biopharma Company Information
        11.10.2 Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
        11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Aurora Biopharma Main Business Overview
        11.10.5 Aurora Biopharma Latest Developments
    11.11 Autolus Therapeutics PLC
        11.11.1 Autolus Therapeutics PLC Company Information
        11.11.2 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
        11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Autolus Therapeutics PLC Main Business Overview
        11.11.5 Autolus Therapeutics PLC Latest Developments
    11.12 Bluebird
        11.12.1 Bluebird Company Information
        11.12.2 Bluebird Adoptive Cell Transfer Therapy Product Offered
        11.12.3 Bluebird Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Bluebird Main Business Overview
        11.12.5 Bluebird Latest Developments
    11.13 Carina Biotech
        11.13.1 Carina Biotech Company Information
        11.13.2 Carina Biotech Adoptive Cell Transfer Therapy Product Offered
        11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Carina Biotech Main Business Overview
        11.13.5 Carina Biotech Latest Developments
    11.14 Athenex
        11.14.1 Athenex Company Information
        11.14.2 Athenex Adoptive Cell Transfer Therapy Product Offered
        11.14.3 Athenex Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Athenex Main Business Overview
        11.14.5 Athenex Latest Developments
    11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
        11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Information
        11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
        11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Main Business Overview
        11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
    11.16 Hengrui Yuanzheng
        11.16.1 Hengrui Yuanzheng Company Information
        11.16.2 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
        11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Hengrui Yuanzheng Main Business Overview
        11.16.5 Hengrui Yuanzheng Latest Developments
    11.17 Eureka Therapeutics
        11.17.1 Eureka Therapeutics Company Information
        11.17.2 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
        11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Eureka Therapeutics Main Business Overview
        11.17.5 Eureka Therapeutics Latest Developments
    11.18 WuXi Juno
        11.18.1 WuXi Juno Company Information
        11.18.2 WuXi Juno Adoptive Cell Transfer Therapy Product Offered
        11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 WuXi Juno Main Business Overview
        11.18.5 WuXi Juno Latest Developments
    11.19 Shenzhen Inno Immunity
        11.19.1 Shenzhen Inno Immunity Company Information
        11.19.2 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
        11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 Shenzhen Inno Immunity Main Business Overview
        11.19.5 Shenzhen Inno Immunity Latest Developments
    11.20 Shenzhen Binde Bio
        11.20.1 Shenzhen Binde Bio Company Information
        11.20.2 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
        11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.20.4 Shenzhen Binde Bio Main Business Overview
        11.20.5 Shenzhen Binde Bio Latest Developments
    11.21 Kerui Bio
        11.21.1 Kerui Bio Company Information
        11.21.2 Kerui Bio Adoptive Cell Transfer Therapy Product Offered
        11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.21.4 Kerui Bio Main Business Overview
        11.21.5 Kerui Bio Latest Developments
    11.22 Adaptimmune
        11.22.1 Adaptimmune Company Information
        11.22.2 Adaptimmune Adoptive Cell Transfer Therapy Product Offered
        11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.22.4 Adaptimmune Main Business Overview
        11.22.5 Adaptimmune Latest Developments
    11.23 Altor Bioscience Corporation
        11.23.1 Altor Bioscience Corporation Company Information
        11.23.2 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
        11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.23.4 Altor Bioscience Corporation Main Business Overview
        11.23.5 Altor Bioscience Corporation Latest Developments
    11.24 Cellectis
        11.24.1 Cellectis Company Information
        11.24.2 Cellectis Adoptive Cell Transfer Therapy Product Offered
        11.24.3 Cellectis Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.24.4 Cellectis Main Business Overview
        11.24.5 Cellectis Latest Developments
    11.25 Takara Bio
        11.25.1 Takara Bio Company Information
        11.25.2 Takara Bio Adoptive Cell Transfer Therapy Product Offered
        11.25.3 Takara Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.25.4 Takara Bio Main Business Overview
        11.25.5 Takara Bio Latest Developments
    11.26 Unum Therapeutics
        11.26.1 Unum Therapeutics Company Information
        11.26.2 Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
        11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.26.4 Unum Therapeutics Main Business Overview
        11.26.5 Unum Therapeutics Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Adoptive Cell Transfer Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of NK
    Table 3. Major Players of LAK
    Table 4. Major Players of DC
    Table 5. Major Players of CIK
    Table 6. Major Players of CTL
    Table 7. Major Players of TIL
    Table 8. Major Players of TCR-T
    Table 9. Major Players of CAR-T
    Table 10. Adoptive Cell Transfer Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 12. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
    Table 13. Adoptive Cell Transfer Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 14. Global Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 15. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
    Table 16. Global Adoptive Cell Transfer Therapy Revenue by Players (2020-2022) & ($ Millions)
    Table 17. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player (2020-2022)
    Table 18. Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
    Table 19. Adoptive Cell Transfer Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 20. New Products and Potential Entrants
    Table 21. Mergers & Acquisitions, Expansion
    Table 22. Global Adoptive Cell Transfer Therapy Market Size by Regions 2017-2022 & ($ Millions)
    Table 23. Global Adoptive Cell Transfer Therapy Market Size Market Share by Regions (2017-2022)
    Table 24. Americas Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & ($ Millions)
    Table 25. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Country (2017-2022)
    Table 26. Americas Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 27. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
    Table 28. Americas Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 29. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
    Table 30. APAC Adoptive Cell Transfer Therapy Market Size by Region (2017-2022) & ($ Millions)
    Table 31. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region (2017-2022)
    Table 32. APAC Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 33. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
    Table 34. APAC Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 35. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
    Table 36. Europe Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & ($ Millions)
    Table 37. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country (2017-2022)
    Table 38. Europe Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
    Table 40. Europe Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
    Table 42. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Region (2017-2022) & ($ Millions)
    Table 43. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region (2017-2022)
    Table 44. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 45. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
    Table 46. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 47. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
    Table 48. Key Market Drivers & Growth Opportunities of Adoptive Cell Transfer Therapy
    Table 49. Key Market Challenges & Risks of Adoptive Cell Transfer Therapy
    Table 50. Key Industry Trends of Adoptive Cell Transfer Therapy
    Table 51. Global Adoptive Cell Transfer Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 52. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Regions (2023-2028)
    Table 53. Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 54. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Type (2023-2028)
    Table 55. Global Adoptive Cell Transfer Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 56. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Application (2023-2028)
    Table 57. Novartis AG Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 58. Novartis AG Adoptive Cell Transfer Therapy Product Offered
    Table 59. Novartis AG Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Novartis AG Main Business
    Table 61. Novartis AG Latest Developments
    Table 62. Kite Pharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 63. Kite Pharma Adoptive Cell Transfer Therapy Product Offered
    Table 64. Kite Pharma Main Business
    Table 65. Kite Pharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 66. Kite Pharma Latest Developments
    Table 67. Pfizer Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 68. Pfizer Adoptive Cell Transfer Therapy Product Offered
    Table 69. Pfizer Main Business
    Table 70. Pfizer Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 71. Pfizer Latest Developments
    Table 72. Juno Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 73. Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
    Table 74. Juno Therapeutics Main Business
    Table 75. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 76. Juno Therapeutics Latest Developments
    Table 77. Celgene Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 78. Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
    Table 79. Celgene Corporation Main Business
    Table 80. Celgene Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 81. Celgene Corporation Latest Developments
    Table 82. CARsgen Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 83. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
    Table 84. CARsgen Therapeutics Main Business
    Table 85. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 86. CARsgen Therapeutics Latest Developments
    Table 87. Sorrento Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 88. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
    Table 89. Sorrento Therapeutics Main Business
    Table 90. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 91. Sorrento Therapeutics Latest Developments
    Table 92. Legend Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 93. Legend Biotech Adoptive Cell Transfer Therapy Product Offered
    Table 94. Legend Biotech Main Business
    Table 95. Legend Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 96. Legend Biotech Latest Developments
    Table 97. Atara Biotherapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 98. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
    Table 99. Atara Biotherapeutics Main Business
    Table 100. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 101. Atara Biotherapeutics Latest Developments
    Table 102. Aurora Biopharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 103. Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
    Table 104. Aurora Biopharma Main Business
    Table 105. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 106. Aurora Biopharma Latest Developments
    Table 107. Autolus Therapeutics PLC Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 108. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
    Table 109. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. Autolus Therapeutics PLC Main Business
    Table 111. Autolus Therapeutics PLC Latest Developments
    Table 112. Bluebird Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 113. Bluebird Adoptive Cell Transfer Therapy Product Offered
    Table 114. Bluebird Main Business
    Table 115. Bluebird Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 116. Bluebird Latest Developments
    Table 117. Carina Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 118. Carina Biotech Adoptive Cell Transfer Therapy Product Offered
    Table 119. Carina Biotech Main Business
    Table 120. Carina Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 121. Carina Biotech Latest Developments
    Table 122. Athenex Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 123. Athenex Adoptive Cell Transfer Therapy Product Offered
    Table 124. Athenex Main Business
    Table 125. Athenex Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 126. Athenex Latest Developments
    Table 127. Xiangxue Pharmaceutical (Xiangxue Precision) Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 128. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
    Table 129. Xiangxue Pharmaceutical (Xiangxue Precision) Main Business
    Table 130. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 131. Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
    Table 132. Hengrui Yuanzheng Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 133. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
    Table 134. Hengrui Yuanzheng Main Business
    Table 135. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 136. Hengrui Yuanzheng Latest Developments
    Table 137. Eureka Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 138. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
    Table 139. Eureka Therapeutics Main Business
    Table 140. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 141. Eureka Therapeutics Latest Developments
    Table 142. WuXi Juno Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 143. WuXi Juno Adoptive Cell Transfer Therapy Product Offered
    Table 144. WuXi Juno Main Business
    Table 145. WuXi Juno Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 146. WuXi Juno Latest Developments
    Table 147. Shenzhen Inno Immunity Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 148. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
    Table 149. Shenzhen Inno Immunity Main Business
    Table 150. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 151. Shenzhen Inno Immunity Latest Developments
    Table 152. Shenzhen Binde Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 153. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
    Table 154. Shenzhen Binde Bio Main Business
    Table 155. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 156. Shenzhen Binde Bio Latest Developments
    Table 157. Kerui Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 158. Kerui Bio Adoptive Cell Transfer Therapy Product Offered
    Table 159. Kerui Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 160. Kerui Bio Main Business
    Table 161. Kerui Bio Latest Developments
    Table 162. Adaptimmune Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 163. Adaptimmune Adoptive Cell Transfer Therapy Product Offered
    Table 164. Adaptimmune Main Business
    Table 165. Adaptimmune Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 166. Adaptimmune Latest Developments
    Table 167. Altor Bioscience Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 168. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
    Table 169. Altor Bioscience Corporation Main Business
    Table 170. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 171. Altor Bioscience Corporation Latest Developments
    Table 172. Cellectis Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 173. Cellectis Adoptive Cell Transfer Therapy Product Offered
    Table 174. Cellectis Main Business
    Table 175. Cellectis Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 176. Cellectis Latest Developments
    Table 177. Takara Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 178. Takara Bio Adoptive Cell Transfer Therapy Product Offered
    Table 179. Takara Bio Main Business
    Table 180. Takara Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 181. Takara Bio Latest Developments
    Table 182. Unum Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
    Table 183. Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
    Table 184. Unum Therapeutics Main Business
    Table 185. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 186. Unum Therapeutics Latest Developments
List of Figures
    Figure 1. Adoptive Cell Transfer Therapy Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Adoptive Cell Transfer Therapy Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021
    Figure 7. Adoptive Cell Transfer Therapy in Acute Lymphocytic Leukemia
    Figure 8. Global Adoptive Cell Transfer Therapy Market: Acute Lymphocytic Leukemia (2017-2022) & ($ Millions)
    Figure 9. Adoptive Cell Transfer Therapy in NHL
    Figure 10. Global Adoptive Cell Transfer Therapy Market: NHL (2017-2022) & ($ Millions)
    Figure 11. Adoptive Cell Transfer Therapy in Melanoma
    Figure 12. Global Adoptive Cell Transfer Therapy Market: Melanoma (2017-2022) & ($ Millions)
    Figure 13. Adoptive Cell Transfer Therapy in Bladder Cancer
    Figure 14. Global Adoptive Cell Transfer Therapy Market: Bladder Cancer (2017-2022) & ($ Millions)
    Figure 15. Adoptive Cell Transfer Therapy in Lung Cancer
    Figure 16. Global Adoptive Cell Transfer Therapy Market: Lung Cancer (2017-2022) & ($ Millions)
    Figure 17. Adoptive Cell Transfer Therapy in Head and Neck Cancer
    Figure 18. Global Adoptive Cell Transfer Therapy Market: Head and Neck Cancer (2017-2022) & ($ Millions)
    Figure 19. Adoptive Cell Transfer Therapy in Multiple Myeloma
    Figure 20. Global Adoptive Cell Transfer Therapy Market: Multiple Myeloma (2017-2022) & ($ Millions)
    Figure 21. Adoptive Cell Transfer Therapy in Other
    Figure 22. Global Adoptive Cell Transfer Therapy Market: Other (2017-2022) & ($ Millions)
    Figure 23. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
    Figure 24. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player in 2021
    Figure 25. Global Adoptive Cell Transfer Therapy Market Size Market Share by Regions (2017-2022)
    Figure 26. Americas Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)
    Figure 27. APAC Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)
    Figure 28. Europe Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)
    Figure 29. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)
    Figure 30. Americas Adoptive Cell Transfer Therapy Value Market Share by Country in 2021
    Figure 31. Americas Adoptive Cell Transfer Therapy Consumption Market Share by Type in 2021
    Figure 32. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
    Figure 33. United States Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Canada Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Mexico Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Brazil Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 37. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region in 2021
    Figure 38. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
    Figure 39. China Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Japan Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Korea Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Southeast Asia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 43. India Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 44. Australia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 45. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country in 2021
    Figure 46. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021
    Figure 47. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
    Figure 48. Germany Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 49. France Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 50. UK Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Italy Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 52. Russia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region in 2021
    Figure 54. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021
    Figure 55. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
    Figure 56. Egypt Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 57. South Africa Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 58. Israel Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 59. Turkey Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 61. Americas Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 62. APAC Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 63. Europe Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 64. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 65. United States Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 66. Canada Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 67. Mexico Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 68. Brazil Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 69. China Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 70. Japan Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 71. Korea Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 72. Southeast Asia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 73. India Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 74. Australia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 75. Germany Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 76. France Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 77. UK Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 78. Italy Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 79. Russia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 80. Spain Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 81. Egypt Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 82. South Africa Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 83. Israel Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 84. Turkey Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
    Figure 85. GCC Countries Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Adoptive Cell Transfer Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Adoptive Cell Transfer Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Adoptive Cell Transfer Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports